AVITA Medical (RCEL) Enterprise Value Growth (1y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | AVITA Medical | 121.89 Mn | 103.71 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49.32% |
| Sep 30, 2025 | 58.55% |
| Jun 30, 2025 | 73.96% |
| Mar 31, 2025 | 62.13% |
| Dec 31, 2024 | 54.19% |
| Sep 30, 2024 | 35.02% |
| Jun 30, 2024 | 10.30% |
| Mar 31, 2024 | 2.87% |
| Dec 31, 2023 | 1.26% |
| Sep 30, 2023 | 22.89% |
| Jun 30, 2023 | 28.73% |
| Mar 31, 2023 | 8.16% |
| Dec 31, 2022 | 7.05% |
| Sep 30, 2022 | 13.75% |
| Jun 30, 2022 | 23.79% |
| Mar 31, 2022 | 33.58% |
| Dec 31, 2021 | -42.35% |
| Sep 30, 2021 | -37.05% |
| Jun 30, 2021 | -50.25% |
| Dec 31, 2020 | -202.85% |
| Jun 30, 2020 | -611.01% |
| Jun 30, 2019 | -261.96% |